NCT06115603View on ClinicalTrials.gov

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 14, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
DRUG

Cannabigerol

1 mL of 80mg Cannabigerol once during experimental session

OTHER

Placebo

1 mL of placebo once during experimental session

Trial Locations (1)

72703

RECRUITING

University of Arkansas, Fayetteville

All Listed Sponsors
lead

University of Arkansas, Fayetteville

OTHER